CAS 313380-27-7

SALOR-INT L224693-1EA

CAS : 313380-27-7

Formule : C₁₉H₁₁F₄N₃OS₂

Degré de pureté : 97%

Couleur et forme : Solid

Masse moléculaire : 437.4338

Ref: IN-DA00CN9T

3-Amino-6-Thiophen-2-Yl-4-Trifluoromethyl-Thieno[2,3-B]Pyridine-2-Carboxylic Acid (4-Fluoro-Phenyl)-Amide

CAS : 313380-27-7

3-Amino-6-Thiophen-2-Yl-4-Trifluoromethyl-Thieno[2,3-B]Pyridine-2-Carboxylic Acid (4-Fluoro-Phenyl)-Amide

Degré de pureté : 97%

Masse moléculaire : 437.43g/mol

Ref: 54-PC105210

FDI-6

CAS : 313380-27-7

FDI-6

Degré de pureté : ≥98%

Masse moléculaire : 437.43g/mol

Ref: 54-BUP09357

FDI-6

CAS : 313380-27-7

FDI-6 is an effective and selective inhibitor of FOXM1 that blocks DNA binding. FDI-6 binds to the FOXM1 protein and downregulates FOXM1-activated genes.

Formule : C₁₉H₁₁F₄N₃OS₂

Degré de pureté : 98.92% - >99.99%

Couleur et forme : Solid

Masse moléculaire : 437.43

Ref: TM-T4005

FDI-6

CAS : 313380-27-7

FDI-6 is a novel anti-cancer prodrug that is activated by the enzyme cytochrome p450. It has been shown to induce apoptotic cell death in hematopoietic cells and cancer cells, as well as inhibit the growth of hepatocellular carcinoma (HCC) cells. FDI-6 induces apoptotic cell death in hematopoietic cells by stimulating the mitochondrial pathway of apoptosis and inhibiting mitochondrial membrane permeability. FDI-6 also inhibits HCC cells by inducing apoptosis and increasing the levels of reactive oxygen species (ROS) in these cancerous cells.
FDI-6 has been shown to be effective against chemotherapy resistant cancer cells due to its ability to induce DNA damage. FDI-6 also has a beneficial effect on biochemical markers of metabolic disorders such as hypertriglyceridemia and hypercholesterolemia, suggesting that it may have therapeutic potential for treating these diseases.

Formule : C₁₉H₁₁F₄N₃OS₂

Degré de pureté : Min. 95%

Masse moléculaire : 437.43 g/mol

Ref: 3D-NMA38027